Literature DB >> 17326009

All-trans-retinoic acid and 13-cis-retinoic acid: pharmacokinetics and biological activity in different cell culture models of human keratinocytes.

M Schroeder1, C C Zouboulis.   

Abstract

Despite its known biological effect on epithelial cells, 13- CIS-retinoic acid shows low binding affinity to either cellular retinoic acid-binding proteins or nuclear retinoid receptors compared to its isomer all- TRANS-retinoic acid. We have postulated a prodrug-drug relation with 13- CIS-retinoic acid which isomerizes to all- TRANS-retinoic acid. On the other hand, the biological effects of these two compounds can differ in the widely used cell culture models of HaCaT and normal primary keratinocytes. In this study, we seeded HaCaT and normal keratinocytes at high densities leading to early confluence in order to imitate high keratinocyte proliferation, such as in acne and psoriasis, while to model decreased keratinocyte proliferation, as in aged and steroid-damaged skin, cells were seeded at a low density. High performance liquid chromatography was administered to examine retinoid uptake and metabolism in monolayer HaCaT and normal keratinocyte cultures and the 4-methylumbelliferyl heptanoate assay to estimate cell growth at different cell densities. Major qualitative and quantitative differences were detected in the two cell types regarding intracellular 13- CIS-retinoic acid isomerization to all- TRANS-retinoic acid. On the other hand, the two retinoic acid isomers showed similar effects on cell growth of both cell types tested with increasing proliferation at low cell densities, but being rather inactive at high ones in normal keratinocytes and exhibiting an antiproliferative effect in HaCaT keratinocytes. The missing effect of retinoids on cell proliferation in high seeding densities of normal keratinocytes may indicate that the normalizing activity of retinoids on hyperkeratotic diseases, such as acne or psoriasis, is likely to be carried out by modulation of cell differentiation than cell growth. On the other hand, induced keratinocyte proliferation in low seeding densities may provide an explanation for the acanthosis induced by topical retinoids in aged and steroid-damaged skin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17326009     DOI: 10.1055/s-2007-961813

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  7 in total

1.  Role of FGFR2-signaling in the pathogenesis of acne.

Authors:  Bodo C Melnik
Journal:  Dermatoendocrinol       Date:  2009-05

Review 2.  Drugs for discoid lupus erythematosus.

Authors:  Sue Jessop; David A Whitelaw; Matthew J Grainge; Prativa Jayasekera
Journal:  Cochrane Database Syst Rev       Date:  2017-05-05

3.  Synthesis and activity of the salicylic acid ester of bakuchiol in psoriasis-surrogate keratinocytes and skin substitutes.

Authors:  S Ma; K Gobis; W R Swindell; R Chaudhuri; R Bojanowski; K Bojanowski
Journal:  Clin Exp Dermatol       Date:  2017-01-04       Impact factor: 3.470

4.  Dietary intervention in acne: Attenuation of increased mTORC1 signaling promoted by Western diet.

Authors:  Bodo Melnik
Journal:  Dermatoendocrinol       Date:  2012-01-01

Review 5.  Illuminating the Role of Vitamin A in Skin Innate Immunity and the Skin Microbiome: A Narrative Review.

Authors:  Fritzlaine C Roche; Tamia A Harris-Tryon
Journal:  Nutrients       Date:  2021-01-21       Impact factor: 5.717

6.  Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology.

Authors:  Ediléia Bagatin; Caroline Sousa Costa; Marco Alexandre Dias da Rocha; Fabíola Rosa Picosse; Cristhine Souza Leão Kamamoto; Rodrigo Pirmez; Mayra Ianhez; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2020-10-03       Impact factor: 1.896

7.  High-throughput hyperdimensional vertebrate phenotyping.

Authors:  Carlos Pardo-Martin; Amin Allalou; Jaime Medina; Peter M Eimon; Carolina Wählby; Mehmet Fatih Yanik
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.